Ploxira 2mg Capsule is a novel pain-relieving medication formulated with Polmacoxib, an active constituent belonging to the class of Selective Cyclooxygenase-2 (COX-2) inhibitors. This therapeutic classification makes it a targeted option for managing pain and inflammation associated with conditions like osteoarthritis. Its selective action on COX-2 enzymes helps minimise inflammation and discomfort without significantly affecting COX-1, reducing the likelihood of gastrointestinal side effects commonly associated with traditional NSAIDs.

This medication is primarily used for conditions requiring long-term pain management, particularly in individuals where traditional NSAIDs may pose a higher risk of adverse effects. However, caution is essential when prescribing to individuals with a history of cardiovascular conditions, gastrointestinal bleeding, or severe liver or kidney impairment.

To ensure safety, Ploxira 2mg Capsule should only be used under medical supervision. Pregnant or breastfeeding women are advised to consult their healthcare provider before starting this medication. It is also contraindicated in individuals with known hypersensitivity to Polmacoxib or other NSAIDs. Adhering to the prescribed dosage and reporting any unusual symptoms can help optimise its benefits while minimising potential risks.

Ploxira 2mg Capsule is indicated for:

• Relief of pain and inflammation in conditions such as osteoarthritis.

• Management of other inflammatory disorders as advised by a healthcare provider.

Ploxira 2mg Capsule effectively reduces pain and inflammation by selectively inhibiting enzymes involved in inflammatory responses. This helps in improving joint mobility and quality of life for individuals with chronic inflammatory conditions.

1. Omeprazole or Esomeprazole (Severe)
   Proton pump inhibitors may reduce clopidogrel’s effectiveness by interfering with its activation, potentially lowering its anti-platelet effect. Doctors may recommend alternative medications or timing adjustments.

2. Warfarin or Other Anticoagulants (Severe)
   Combining clopidogrel with blood thinners can significantly increase the risk of bleeding. Close monitoring of INR or clotting parameters is essential.

3. NSAIDs (Severe)
   Pain relievers such as ibuprofen, naproxen, or diclofenac may amplify bleeding risk when taken with clopidogrel. Use under medical supervision is advised.

4. Selective Serotonin Reuptake Inhibitors (SSRIs) (Moderate)
   Antidepressants like sertraline or fluoxetine may slightly increase bleeding tendency when combined with clopidogrel. Monitoring for unusual bleeding is recommended.

5. Other Antiplatelet Agents (Moderate)
   Drugs like prasugrel or ticagrelor may enhance clopidogrel’s blood-thinning effects, raising bleeding risk. Doctors generally adjust therapy to avoid excessive bleeding.

6. St. John’s Wort (Mild)
   This herbal supplement may slightly reduce clopidogrel’s effectiveness by increasing its breakdown in the liver. Medical guidance is advised if both are used.

• Store Ploxira 2mg Capsule in a cool, dry place below 25°C.

• Keep the medication out of reach of children and pets.

• If you miss a dose, take it as soon as you remember unless it's almost time for your next dose.

• In case of an overdose, seek immediate medical help.

• Avoid alcohol and spicy foods while using this medication.

Take Ploxira 2mg Capsule exactly as prescribed by your doctor. It is typically taken orally, with or without food, to reduce gastrointestinal discomfort. Maintain consistent timing for better efficacy. Do not exceed the recommended dosage.

Common side effects of Ploxira 2mg Capsule include:

• Nausea

• Stomach pain

• Dizziness

• Diarrhea

Seek medical attention immediately if you experience severe side effects like chest pain, difficulty breathing, or signs of an allergic reaction such as rash or swelling.

• Always take Ploxira 2mg Capsule as directed by your doctor.

• Keep track of any new symptoms and report them to your healthcare provider.

• Regular check-ups are essential, especially for individuals with a history of cardiovascular, kidney, or gastrointestinal conditions.